Energy News  
CLONE AGE
Reprogrammed Stem Cells Hit A Roadblock

File image.
by Staff Writers
Lausanne, Switzerland (SPX) Feb 24, 2011
It's a discordant note in the symphony of good news that usually accompanies stem cell research announcements. Stem cells hold enormous promise in regenerative medicine, thanks to their ability to regenerate diseased or damaged tissues. They have made it possible to markedly improve the effectiveness of many medical treatments - muscle regeneration in cases of dystrophy, skin grafts for treating burn victims, and the treatment of leukemia via bone marrow transplants.

The problem is obtaining them. Those that are the true source of life, in the first days of embryonic development, are of course the most highly sought after; still undifferentiated, they are "pluripotent," meaning they can evolve into liver, muscle, eye - any kind of cell. But the issue of how to obtain them clearly raises insurmountable ethical questions.

"In this regard, the recent discovery of the "reprogramming" phenomenon, by which somatic cells can be induced to convert to a pluripotent state simply by forcing the expression of a few genes, opens a phenomenal number of possibilities in regenerative medicine," says Didier Trono, Dean of the EPFL School of Life Sciences.

"Imagine, for example, collecting a few cells from the hair follicle of a hemophiliac patient, reprogramming them to the pluripotentiality of their embryonic precursor, correcting the mutation responsible for the coagulation disorder that plagues the patient, and then re-administering them, genetically "cured," after having orchestrated a differentiation into fully functional progeny."

Increased risks for cancer?
But a study that has just been published in the journal Cell Death and Differentiation, to be followed by two articles in the journal Nature, is dampening those hopes. Conducted by the Department of Biochemistry at the University of Geneva and the European Institute of Oncology in Milan, with the participation of Trono's laboratory, it concludes that these reprogrammed cells exhibit a "genomic instability" that appears to be caused by the process used to return the cells to their embryonic state.

Even more serious, the genetic mutations observed resemble mutations that are found in cancer cells. The scientists draw the conclusion that reprogrammed stem cells need to be extensively investigated before they can even be considered for use in regenerative medicine.

The experiments were done using mouse mammary and fibroblast cells. The researchers used three different processes for reprogramming the cells to a "stem," or embryonic, state. The first method was developed expressly for this study, and the others have already been well documented.

Yet all the processes led to the same, implacable conclusion: the genetic anomalies multiplied, in a manner that seems to indicate that they are inherent to the reprogramming process itself, which typically makes use of oncogenes. "Interestingly, oncogenes have the potential to induce genomic instability," the authors explain.

These results underline the necessity of conducting further studies.

First, to see if the genetic anomalies are serious enough to compromise the function and stability of cells regenerated using the reprogrammed cells; and second, to "refine the methods used for generating induced pluripotent cells, in order to avoid this problem. These results will thus motivate scientists to come up with a solution," concludes Trono.



Share This Article With Planet Earth
del.icio.usdel.icio.us DiggDigg RedditReddit
YahooMyWebYahooMyWeb GoogleGoogle FacebookFacebook



Related Links
Ecole Polytechnique Federale de Lausanne
The Clone Age - Cloning, Stem Cells, Space Medicine



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


CLONE AGE
Stem Cell Discovery Could Lead To Improved Bone Marrow Transplants
Santa Cruz CA (SPX) Jan 11, 2011
Researchers at the University of California, Santa Cruz, have identified a key molecule for establishing blood stem cells in their niche within the bone marrow. The findings, reported in the January issue of Cell Stem Cell, may lead to improvements in the safety and efficiency of bone marrow transplants. Bone marrow transplants are a type of stem cell therapy used to treat cancers such as ... read more







CLONE AGE
Gravity Lensing Brightens Distant Galaxies

Study Predicts Distribution Of Gravitational Wave Sources

CLONE AGE
EPSRC's Novel Energy Harvesting Grants

German Solar Market Doubled In 2010

DuPont Microcircuit Materials Launches Next Gen Frontside Silver PV Metallizations

Solar Frontier Starts Production At World's Largest CIS Solar Module Plant

CLONE AGE
Eon to build fifth U.K. offshore wind farm

GL Garrad Hassan Launches Onshore Wind Resource Mapping For UK

Construction Begins On Dempsey Ridge Wind Project

India's Suzlon wins $1.28 bn wind power deal

CLONE AGE
Hong Kong tycoon 'set to clinch British power business'

Germany's RWE sees tough years ahead

S.Korea, China firms in Vietnam power deal

Energy sector deals to increase, PwC says

CLONE AGE
British military planes in dramatic Libyan desert rescue

Iraq attack prompts refinery closure

Asian evacuees tell of Libya turmoil

Mass evacuations from Libya criss-cross Mediterranean

CLONE AGE
'Missing' element gives planet birth clues

'Wandering' planets may have water, life

Back To The Roots Of The Solar System

Direct Images Of Disks Unravel Mystery Of Planet Formation

CLONE AGE
US military to boost naval fleet in Asia

Northrop Grumman To Outfit Littoral Combat Ship Mission Package Containers

New Zealand starts frigate systems upgrade

Onr Develops New Acquisition Model For Delivering Information To The Fleet

CLONE AGE
Advanced NASA Instrument Gets Close-up On Mars Rocks

Good Health Report After Hiatus In Communications

Experiment volunteers take 2nd 'walk on Mars'

Walking On Mars


The content herein, unless otherwise known to be public domain, are Copyright 1995-2010 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement